IP Library Granted Patent US 10,064,723
Granted Patent B2
US 10,064,723 · App. 15/162,029 · Granted Sep 4, 2018

Cardiac treatment system and method

Inventors: Aaron J. Hjelle (Andover, MN); William E. Cohn (Bellaire, TX); Richard F. Schroeder (Fridley, MN); James F. Buck (Independence, MN); Karl R. Leinsing (Dover, NH)
Assignee: Mardil, Inc.
A61F2/2481A61M1/106A61M1/107A61M1/1008D04B21/12A61B2090/3966A61F2002/2484A61F2002/9517A61F2250/0003A61F2250/0098A61M1/1068A61M1/12A61M1/122A61M2205/32D10B2509/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,064,723
App. No.
15/162,029
Granted
Sep 4, 2018
Kind
B2
Abstract

Devices and methods for providing localized pressure to a region of a patient's heart to improve heart functioning, including: (a) a jacket made of a flexible biocompatible material, the jacket having an open top end that is received around the heart and a bottom portion that is received around the apex of the heart; and (b) at least one inflatable bladder disposed on an interior surface of the jacket, the inflatable bladder having an inelastic outer surface positioned adjacent to the jacket and an elastic inner surface such that inflation of the bladder causes the bladder to deform substantially inwardly to exert localized pressure against a region of the heart.

Claims (38)

1. A method of treating heart valve dysfunction, the method comprising:

putting contrast agent solution into contact with epicardial tissue of a heart and using radiographic imaging to visualize an atrial-ventricular (AV) groove of the heart;

positioning a cardiac support device (CSD) around a ventricular portion of the heart, wherein the CSD includes a plurality of radiopaque markers on an open distal end of the CSD, and wherein said positioning includes advancing the open distal end of the CSD over an apex of the heart and using radiographic imaging to position the plurality of radiopaque markers on the open distal of the CSD in the AV groove;

allowing a time period to pass so that fibrotic encapsulation of the CSD on the heart can occur; and

after the time period has passed, adjusting the CSD to treat valvular dysfunction.

2. The method of claim 1 , wherein the CSD includes an inflatable bladder, and wherein said positioning includes aligning the inflatable bladder with a targeted surface region on a wall of the heart.

3. The method of claim 2 , wherein the targeted surface region is adjacent a mitral valve or a tricuspid valve.

4. The method of claim 2 , wherein the CSD includes an inflation tube in fluid communication with the inflatable bladder, and wherein said positioning includes positioning a free end of the inflation tube in an intercostal space just below an epidermal layer.

5. The method of claim 4 , wherein said adjusting the CSD to treat valvular dysfunction includes:

accessing the free end of the inflation tube; and

adding fluid, via the inflation tube, into the inflatable bladder to expand the inflatable bladder, wherein said expansion of the inflatable bladder applies a localized pressure against the targeted surface region on the wall of the heart to reshape the heart.

6. The method of claim 1 , wherein the method is performed while the heart is beating.

7. The method of claim 1 , wherein the time period is at least one week.

8. A method of treating heart valve dysfunction, the method comprising:

creating an intercostal incision;

measuring a ventricular perimeter of a heart using an intra-operative sizing device inserted through the intercostal incision;

after said measuring, positioning a cardiac support device (CSD) around a ventricular portion of the heart;

allowing a time period to pass so that fibrotic encapsulation of the CSD on the heart can occur; and

after the time period has passed, adjusting the CSD to treat valvular dysfunction.

9. The method of claim 8 , wherein said adjusting the CSD to treat valvular dysfunction includes adding fluid into an inflatable bladder to cause expansion of the inflatable bladder to apply localized pressure against the heart.

10. The method of claim 9 , wherein the CSD includes an inflation tube in fluid communication with the inflatable bladder, and wherein said positioning the CSD includes positioning a free end of the inflation tube in an intercostal space just below an epidermal layer.

11. The method of claim 10 , wherein said adjusting the CSD to treat valvular dysfunction includes accessing the free end of the inflation tube, and wherein the fluid is added into the inflatable bladder via the inflation tube.

12. A method of treating heart valve dysfunction, the method comprising:

positioning a cardiac support device (CSD) around a ventricular portion of a heart:

after said positioning the CSD, trimming a proximal portion of the CSD and closing a trimmed end of the CSD around an apex of the heart;

allowing a time period to pass so that fibrotic encapsulation of the CSD on the heart can occur; and

after the time period has passed, adjusting the CSD to treat valvular dysfunction.

13. The method of claim 12 , wherein said adjusting the CSD to treat valvular dysfunction includes adding fluid into an inflatable bladder to cause expansion of the inflatable bladder to apply localized pressure against the heart.

14. The method of claim 13 , wherein the CSD includes an inflation tube in fluid communication with the inflatable bladder, and wherein said positioning the CSD includes positioning a free end of the inflation tube in an intercostal space just below an epidermal layer.

15. The method of claim 14 , wherein said adjusting the CSD to treat valvular dysfunction includes accessing the free end of the inflation tube, and wherein the fluid is added into the inflatable bladder via the inflation tube.

16. The method of claim 15 , further comprising monitoring valvular regurgitation to evaluate said adjusting the CSD to treat valvular dysfunction.

17. A method of treating a human patient, the method comprising:

positioning a cardiac support device (CSD) onto a ventricular portion of a heart of the patient;

after said positioning the CSD, waiting for an at least one week period of time; and

after said waiting for the at least one week period of time, adjusting the CSD to improve functioning of the heart, wherein said adjusting the CSD to improve the heart's function reduces valvular regurgitation by modifying a shape of the heart, and wherein said modifying the shape of the heart includes deflecting papillary muscles of the heart.

18. The method of claim 17 , wherein the at least one week period of time is an at least three week period of time.

19. The method of claim 17 , wherein said adjusting the CSD to improve functioning of the heart includes expanding a fillable bladder of the CSD to exert a localized pressure against a targeted surface region on a wall of the heart to reshape a valve of the heart.

20. The method of claim 19 , wherein said adjusting the CSD to improve functioning of the heart includes, during said expanding the fillable bladder, monitoring valvular regurgitation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: MARDIL, INC.
To: DIAXAMED, LLC
Reel/Frame 056051/0759 →
SECURITY INTEREST Recorded Nov 28, 2018
From: MARDIL, INC.
To: COSMOS GROUP, LLC
Reel/Frame 047659/0873 →
SECURITY INTEREST Recorded Nov 28, 2018
From: MARDIL, INC.
To: COSMOS GROUP, LLC; MARDIL MEDICAL DEVICES PVT. LTD.
Reel/Frame 048174/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2016
From: HJELLE, AARON J.; COHN, WILLIAM E.; SCHROEDER, RICHARD F.; BUCK, JAMES F.; LEINSING, KARL R.
To: MARDIL, INC.
Reel/Frame 038700/0856 →
Continuity (3)
Continuation 14053590 · Oct 14, 2013
Provisional Application 61713351 · Oct 12, 2012
Related Publication 20160262890A1 · Sep 15, 2016